Statement on the Benefit Assessment of Etrasimod (ulcerative Colitis, ≥ 16 Years)

被引：0
|
作者：
Jansen, Petra Lynen
机构：
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2024年 / 62卷 / 10期
关键词：
INFLAMMATORY-BOWEL-DISEASE; CORTICOSTEROID-THERAPY; ECCO GUIDELINES; THERAPEUTICS;
D O I：
10.1055/a-2414-9330
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1857 / 1861
页数：5
相关论文
共 50 条
  • [21] Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis
    Sandborn, William J.
    Peyrin-Biroulet, Laurent
    Zhang, Jinkun
    Chiorean, Michael
    Vermeire, Severine
    Lee, Scott D.
    Kuehbacher, Tanja
    Yacyshyn, Bruce
    Cabell, Christopher H.
    Naik, Snehal U.
    Klassen, Preston
    Panes, Julian
    GASTROENTEROLOGY, 2020, 158 (03) : 550 - 561
  • [22] ETRASIMOD IMPROVES QUALITY OF LIFE IN ADULTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS
    Taylor, Carly
    Chiorean, Michael
    Vermeire, Severine
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Sands, Bruce E.
    Schreiber, Stefan
    Naik, Snehal U.
    Rabbat, Christopher J.
    Akhundova-Unadkat, Gamar
    Sandborn, William J.
    GUT, 2022, 71 : A143 - A143
  • [23] Benefit–Risk Assessment of Vedolizumab in the Treatment of Crohn’s Disease and Ulcerative Colitis
    Robert Battat
    Christopher Ma
    Vipul Jairath
    Reena Khanna
    Brian G. Feagan
    Drug Safety, 2019, 42 : 617 - 632
  • [24] Concomitant Use of Etrasimod With Opioids or Antidepressants in Patients With Ulcerative Colitis-A Safety Analysis
    Afzali, Anita
    Regueiro, Miguel
    Yarur, Andres J.
    Zabana, Yamile
    Ng, Siew C.
    Menon, Sujatha
    Mcdonnell, Aoibhinn
    Lazin, Krisztina
    Keating, Michael
    Bhattacharjee, Abhishek
    Branquinho, Diogo
    Bananis, Eustratios
    Peyrin-Biroulet, Laurent
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2025,
  • [25] SURVEILLANCE IN ULCERATIVE-COLITIS - BURDENS AND BENEFIT
    JONES, HW
    GROGONO, J
    HOARE, AM
    GUT, 1988, 29 (03) : 325 - 331
  • [26] Benefit-Risk Assessment of Vedolizumab in the Treatment of Crohn's Disease and Ulcerative Colitis
    Battat, Robert
    Ma, Christopher
    Jairath, Vipul
    Khanna, Reena
    Feagan, Brian G.
    DRUG SAFETY, 2019, 42 (05) : 617 - 632
  • [27] PERSONALITY ASSESSMENT WITH CATTELL 16 PF TEST IN ULCERATIVE-COLITIS PATIENTS
    BOLELOUCKY, Z
    ACTIVITAS NERVOSA SUPERIOR, 1973, 15 (01): : 55 - 56
  • [28] Therapeutic Potential of Etrasimod in the Management of Moderately-to-Severely Active Ulcerative Colitis: Evidence to Date
    Glassner, Kerri
    Fan, Christopher
    Irani, Malcolm
    Abraham, Bincy P.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2024, 17 : 337 - 345
  • [29] Crohn's Disease of the Ileal Pouch 16 Years After Proctocolectomy for Ulcerative Colitis
    Tremaine, William J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (03) : 198 - 201
  • [30] Efficacy of Etrasimod in Patients With Ulcerative Colitis: A Post Hoc Analysis Based on Baseline Endoscopic Subscore
    Yarur, Andres J.
    Reinisch, Walter
    Chang, Shannon
    Gecse, Krisztina B.
    Green, Jesse
    Abbatemarco, Arcangelo M.
    Wu, Joseph
    Goetsch, Martina
    Lazin, Krisztina
    Pradeep, Gokul
    Sands, Bruce E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1025 - S1026
12345